We are live on
!
Find out more
CX Institutional Portfolio holdings
AUM
$3.69B
Turnover
15.61%
1-Year Est. Return
15.82%
This Fund
S&P 500
This Quarter
Est. Return
+12.76%
1 Year Est. Return
+15.82%
3 Year Est. Return
+62.89%
5 Year Est. Return
+60.35%
10 Year Est. Return
–
AUM
$3.46B
AUM Growth
+$187M
(+5.7%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
22.2%
Holding
1,655
New
108
Increased
650
Reduced
544
Closed
87
Avg Time Held
2
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$70.3M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$40M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$24.9M |
| 4 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$12.5M |
| 5 |
Invesco S&P 500 Revenue ETF
RWL
|
+$11.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$42.3M |
| 2 |
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
|
+$27.5M |
| 3 |
VanEck Intermediate Muni ETF
ITM
|
+$19.9M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$18M |
| 5 |
Dell
DELL
|
+$14.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.2% |
| 2 | Technology | 13.16% |
| 3 | Healthcare | 7.56% |
| 4 | Financials | 6.96% |
| 5 | Consumer Discretionary | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1151
Antero Resources
AR
$11.2B
| $22K | ﹤0.01% |
+619
| New | +$22.8K |
2026 Q2
0 quarters
|
|
1152
Aramark
ARMK
$14.4B
| $22K | ﹤0.01% |
394
+2
| +0.5% | +$99 |
2026 Q1
1 quarter
|
|
1153
Corebridge Financial
CRBG
$15.1B
| $22K | ﹤0.01% |
760
+93
| +14% | +$2.52K |
2026 Q1
1 quarter
|
|
1154
iShares MSCI Denmark ETF
EDEN
$183M
| $22K | ﹤0.01% |
196
-1
| -0.5% | -$110 |
2025 Q1
5 quarters
|
|
1155
Fidelity MSCI Financials Index ETF
FNCL
$2.28B
| $22K | ﹤0.01% |
287
+1
| +0.3% | +$74 |
2025 Q1
5 quarters
|
|
1156
Harley-Davidson
HOG
$2.86B
| $22K | ﹤0.01% |
890
+1
| +0.1% | +$24 |
2025 Q1
5 quarters
|
|
1157
Defiance Quantum ETF
QTUM
$5.3B
| $22K | ﹤0.01% |
133
| – | – |
2025 Q4
2 quarters
|
|
1158
Roivant Sciences
ROIV
$24.6B
| $22K | ﹤0.01% |
628
+2
| +0.3% | +$59 |
2026 Q1
1 quarter
|
|
1159
Agnico Eagle Mines
AEM
$93.6B
| $21K | ﹤0.01% |
138
+129
| +1,433% | +$23.9K |
2025 Q4
2 quarters
|
|
1160
abrdn Total Dynamic Dividend Fund
AOD
$1.07B
| $21K | ﹤0.01% |
2,032
+59
| +3% | +$603 |
2025 Q1
5 quarters
|
|
1161
Acuity Brands
AYI
$8.98B
| $21K | ﹤0.01% |
57
| – | – |
2026 Q1
1 quarter
|
|
1162
Calamos Convertible Opportunities and Income Fund
CHI
$911M
| $21K | ﹤0.01% |
1,582
+35
| +2% | +$431 |
2025 Q3
3 quarters
|
|
1163
FT Vest US Equity Buffer ETF December
FDEC
$1.34B
| $21K | ﹤0.01% |
393
| – | – |
2026 Q1
1 quarter
|
|
1164
HCI Group
HCI
$2.44B
| $21K | ﹤0.01% |
118
-36,923
| -100% | -$5.82M |
2025 Q3
3 quarters
|
|
1165
HSBC
HSBC
$323B
| $21K | ﹤0.01% |
223
| – | – |
2025 Q1
5 quarters
|
|
1166
Kite Realty
KRG
$4.91B
| $21K | ﹤0.01% |
732
| – | – |
2025 Q1
5 quarters
|
|
1167
Neurocrine Biosciences
NBIX
$13.9B
| $21K | ﹤0.01% |
126
| – | – |
2026 Q1
1 quarter
|
|
1168
Novo Nordisk
NVO
$174B
| $21K | ﹤0.01% |
444
| – | – |
2025 Q1
5 quarters
|
|
1169
iShares Global Consumer Discretionary ETF
RXI
$306M
| $21K | ﹤0.01% |
111
-6,409
| -98% | -$1.26M |
2025 Q1
5 quarters
|
|
1170
Trade Desk
TTD
$6.13B
| $21K | ﹤0.01% |
1,155
+141
| +14% | +$2.99K |
2025 Q1
5 quarters
|
|
1171
TRI-Continental Corp
TY
$1.84B
| $21K | ﹤0.01% |
616
+14
| +2% | +$480 |
2025 Q1
5 quarters
|
|
1172
United Therapeutics
UTHR
$23.6B
| $21K | ﹤0.01% |
39
| – | – |
2026 Q1
1 quarter
|
|
1173
Vertiv
VRT
$80.1B
| $21K | ﹤0.01% |
62
+11
| +22% | +$3.49K |
2025 Q1
5 quarters
|
|
1174
Woodward
WWD
$19.5B
| $21K | ﹤0.01% |
49
| – | – |
2025 Q3
3 quarters
|
|
1175
FT Vest US Equity Buffer ETF January
FJAN
$1.48B
| $20K | ﹤0.01% |
365
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
CX Institutional's Q2 2026 Portfolio in Review
As of Q2 2026, CX Institutional held 1,655 positions worth $3.46B, up 5.7% from $3.28B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
CX Institutional withdrew a net $129M in Q2 2026, closing 87 positions and reducing 544 holdings. Its most notable exit was State Street SPDR S&P International Small Cap ETF, an estimated $7.62M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
Against the trend, CX Institutional opened a new position in Invesco S&P 500 Revenue ETF worth $11.7M.
- CX Institutional's largest Q2 2026 buy was Invesco S&P 500 Revenue ETF: 91,198 shares worth $11.7M.
- CX Institutional added most to iShares 0-3 Month Treasury Bond ETF in Q2 2026, an estimated $70.3M increase.
- CX Institutional's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $42.3M.
- CX Institutional fully exited State Street SPDR S&P International Small Cap ETF in Q2 2026, selling an estimated $7.62M.
- CX Institutional's ten largest holdings make up 22% of its $3.46B portfolio in Q2 2026.
- CX Institutional opened 108 new positions and closed 87 in Q2 2026.
- CX Institutional's portfolio value rose 5.7% quarter-over-quarter to $3.46B.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.